Fig. 6From: Identifying inflammatory bowel disease patients at risk of metabolic dysfunction-associated fatty liver disease: usefulness of non-invasive steatosis predictive scoresROC curve analysis of MAFLD-S, FLI, HSI and CPN-CD performance for MAFLD prediction in all IBD patientsBack to article page